Evotec has been a leader in drug discovery and development for over 30 years, offering end-to-end solutions from target identification to clinical trials. Their innovative approach leverages deep disease understanding, cutting-edge technologies, and tailored solutions, supporting collaborations through standalone services, integrated programs, or strategic partnerships to create impactful medicines. | Evotec is a life science company pioneering the future of drug discovery and development. By integrating breakthrough science with AI-driven innovation and advanced technologies, we accelerate the journey from concept to cure, faster, smarter, and with greater precision. At the heart of our innovation are proprietary platforms including Molecular Patient Databases, PanOmics, and iPSC-based disease modeling, which uniquely support our expertise in small molecules, biologics, cell therapies, and other key modalities. With flexible partnering models tailored to our customers’ needs, we work with all Top 20 Pharma companies, over 800 biotechs, academic institutions, and healthcare stakeholders. Our offerings range from standalone services to fully integrated R&D programs and long-term strategic partnerships, combining scientific excellence with operational agility. Through Just – Evotec Biologics, we redefine biologics development and manufacturing to improve accessibility and affordability. With a strong portfolio of over 100 proprietary R&D assets, most of them co-owned, we focus on key therapeutic areas including oncology, cardiovascular and metabolic diseases, neurology, and immunology. Evotec’s global team of more than 4,800 experts operates from sites in Europe and the U.S., offering complementary technologies and services as synergistic centers of excellence. Learn more at www.evotec.com and follow us on X/Twitter @Evotec and LinkedIn.
Everest Biolabs
We’re dedicated to reaching excellence in EV research by relentless focus on high-quality, easy-to-use tools for exosome and EV isolation and analytics. Our solutions are designed to enhance researchers’ daily workflows, from foundational EV isolation to advanced analytics, enabling groundbreaking discoveries. With a vision to unlock the potential of EVs in clinical applications, we keep ‘science first’ while fostering innovation and integrity in everything we do. Based in Boston, MA we’re here to elevate exosome research at every step.
Epistem Ltd
Epistem’s oncology team has a solid reputation and extensive experience in guiding therapeutic agents through various stages, including early-stage in vitro proof of concept testing, in vivo efficacy models, and the quantification of target engagement via biomarkers to support clinical studies. Our services are available individually or as part of a comprehensive integrated package. Our analytical capabilities include histology & IHC, pharmacogenomics, advanced imaging and analysis, as well as flow cytometry & cytokine profiling, providing clients with practical and effective support for their research and development needs. We also offer additional models, such as dermatological (in vitro and in vivo), wound healing (in vitro and in vivo), inflammatory diseases (IBD), and organoid models for toxicity testing across four different species.
EpigenTek Group Inc.
EpigenTek is the leading provider of epigenetic assay kits, antibodies, reagents, and services through a complete and systematic approach. We are the first company to specialize exclusively in epigenetics and has pioneered the commercialization of many technologies commonly used today in DNA methylation, RNA methylation, histone modification, and chromatin studies.
Epigenica
At Epigenica, we build innovative products for epigenetic analysis that foster scientific breakthroughs to advance human health.
Enzo Life Sciences
Global Life Sciences Company Serving the Scientific Community for over 50 Years Enzo Life Sciences is a focused global life science company delivering innovative solutions to support biomedical research, translational science, and drug development. For more than 50 years, Enzo has been a leader in product development and technology innovation, serving academic research institutions and biopharma partners worldwide. With a comprehensive portfolio of widely cited and highly trusted quality products—including antibodies, assays, genomic probes, proteins, and biochemicals—Enzo supports a broad range of applications across genomic, protein, cellular, tissue, and small molecule analysis. Proprietary technologies and products play key roles at every stage of translational research and therapeutic development. Enzo Life Sciences’ deep scientific expertise, flexible solutions, and versatile product offerings accelerate research timelines, enabling partners to effectively and efficiently advance discovery and development efforts.
EnquBio
EnquBio is a San Diego-based preclinical CRO built for the complexity of modern drug discovery. We offer an integrated suite of capabilities including biological tissue models, orthotopic in vivo oncology models, iPSC platforms, in vitro pharmacology, and a comprehensive Immunology & Biomarkers platform spanning flow cytometry, MSD multiplex, and protein quantification designed to deliver biologically meaningful, translatable data at every stage of preclinical development. Whether you’re profiling tumor microenvironment biology, evaluating checkpoint inhibitors, advancing ADCs or bispecifics, or characterizing fibrotic or inflammatory disease, EnquBio brings the scientific rigor and platform depth to answer your most critical research questions. We don’t just run assays, we partner with your team to design studies that generate the kind of clean, reproducible, AI-ready data that accelerates decision-making and de-risks your pipeline.
ELK(Wuhan)Biotechnology CO.,Ltd.
ELK Biotechnology is a high-tech biological company focusing on the development and production of immune products and molecular biology products. Products cover ELISA kits, antibodies, genome extraction reagents, molecular biology reagents. Involved in immunochemistry, tumor research, neurobiology, cell cycle, signal transduction and other fields. Our products have strict R&D and quality inspection processes. Each product has complete R&D, production and quality inspection records. Experienced R&D personnel, complete quality inspection support department, and strict inspection process provide customers with reliable quality scientific research products. Company was built since 2013 for domestic market only, since 2018, the company has opened up overseas markets. We have reached stable cooperation with customers in more than 80 countries on 5 continents at home and abroad. High-quality products, complete ordering and delivery and after-sales procedures have won us customers’ support，trust and praise. While developing, we will always implement the concept of environmental protection in the production process, and always take scientific development and environmental protection as the company’s mission. In line with the belief of providing scientists with the most cutting-edge and most cost-effective research tools, we will continue to devote ourselves to providing high-quality scientific research products for scientific researchers and contributing to the development of human life sciences.
Elabscience Bionovation Inc
Elabscience equips both R & D platform and a manufacturing plant, with in-house QC for every product, to ensure consistent and robust experimental results. Elabscience major products cover ELISA Kits, Proteins, Flow cytometry Antibodies, Cell function kits, and Metabolism kits, which have already been cited in numerous publications.
E-BIOT BIOSCIENCE INC.
At e-BLOT, we revolutionized Western blot imaging in 2019 with the launch of the Touch Imager. This innovative chemiluminescence system offers the highest sensitivity and the broadest quantitative range on the market. Our success is built on dedication, expertise, and experience, as we turn challenges and setbacks into opportunities for innovation. Guided by the belief that no challenge is insurmountable, we continuously push the boundaries of imaging technology to meet and exceed our customers’ evolving needs.